I look forward to facilitating the dissemination of cutting edge information via Psoriasis: Targets and Therapy in the hope to advance research in psoriasis.
Auckland, New Zealand (PRWEB) June 25, 2011
This international, peer-reviewed open access journal will focus on therapies for psoriasis and the improvement of outcomes for patients with this disorder.
Dr Bagel, a nationally recognized expert in the treatment of psoriasis, is Director of the Psoriasis Treatment Center of Central New Jersey in East Windsor, and Clinical Associate Professor of Dermatology at the College of Physicians and Surgeons of Columbia University. He is also a senior attending physician at the University Medical Center at Princeton. Dr Bagel also serves on the Medical Advisory Board of the National Psoriasis Foundation. Well published in the peer-reviewed literature, with articles on psoriasis appearing in many journals, he is an active researcher, participating in numerous funded studies focusing on the efficacy of various treatments for psoriasis.
He says, “Mechanism of action of pharmaceutical agents has been a passion of mine since I studied biochemistry in graduate school. I look forward to facilitating the dissemination of cutting edge information via Psoriasis: Targets and Therapy in the hope to advance research in psoriasis.”
Publisher Tim Hill at Dove Medical Press added, “The appointment of Dr Bagel as the Editor-in-Chief of Psoriasis: Targets and Therapy is particularly exciting at this time, with the heightened level of interest in this field internationally. All of us at Dove Medical Press are committed to sustaining the highest levels of editorial integrity, rigorous and constructive peer-review, along with rapid publication times and the presentation of quality research findings.”
Dove Medical Press is a privately held publisher of 100+ open access peer-reviewed journals across the broad spectrum of science, technology and especially medicine. Dove was founded in 2003 and has offices in the United Kingdom and New Zealand, with an active presence in the USA and a network of agents in Europe, the Americas, and Southeast Asia.
# # #